Myeloma News and Research

RSS
Seniors face crushing drug costs as Congress stalls on capping Medicare out-of-pockets

Seniors face crushing drug costs as Congress stalls on capping Medicare out-of-pockets

P2 COVID-19 study shows no material safety differences between opaganib and control arms

P2 COVID-19 study shows no material safety differences between opaganib and control arms

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

Landmark study finds how often cancer patients develop osteonecrosis of the jaw

Landmark study finds how often cancer patients develop osteonecrosis of the jaw

Ohio State receives $10 million gift to establish new myeloma research center

Ohio State receives $10 million gift to establish new myeloma research center

RedHill Biopharma announces promising preliminary results from opaganib study

RedHill Biopharma announces promising preliminary results from opaganib study

Study highlights previously unknown mechanisms involved in myeloma resistance

Study highlights previously unknown mechanisms involved in myeloma resistance

Study finds CAR T cell therapy as effective as first-line treatment for high-risk large B-cell lymphoma

Study finds CAR T cell therapy as effective as first-line treatment for high-risk large B-cell lymphoma

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

More than 40 Dana-Farber studies to be presented at the virtual 62nd ASH Annual Meeting

More than 40 Dana-Farber studies to be presented at the virtual 62nd ASH Annual Meeting

Underrepresented minorities are at increased risk for AL amyloidosis

Underrepresented minorities are at increased risk for AL amyloidosis

Beat AML trial achieves primary endpoint

Beat AML trial achieves primary endpoint

Advancements in research on cancer signal transduction and treatment

Advancements in research on cancer signal transduction and treatment

Radiation therapy before CART-BCMA appears to be a safe option for multiple myeloma patients

Radiation therapy before CART-BCMA appears to be a safe option for multiple myeloma patients

A strategic collaboration to speed up the development of allogeneic cell therapies

A strategic collaboration to speed up the development of allogeneic cell therapies

Researchers are developing a new class of compounds against various cancers

Researchers are developing a new class of compounds against various cancers

CAR T cell therapy can predict treatment response in patients with large B-cell lymphoma

CAR T cell therapy can predict treatment response in patients with large B-cell lymphoma

Challenges in High Complexity Flow Cytometry

Challenges in High Complexity Flow Cytometry

Research uncovers potential cause of neurotoxicity due to immunotherapy

Research uncovers potential cause of neurotoxicity due to immunotherapy

New partnership aims to advance predictive tests for multiple myeloma in Ireland

New partnership aims to advance predictive tests for multiple myeloma in Ireland